Menu
Recruiting NCT07509853

Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand

No phase Interventional HIV Prevention Substance Use Mental Health Sexually Transmitted Infections (STIs)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Pleasuremeter-guided qualitative interview, Pleasuremeter-based sexual pleasure discussion integrated with harm reduction services.
Who it may be relevant to
Registry conditions: HIV Prevention, Substance Use, Mental Health, Sexually Transmitted Infections (STIs). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Thailand
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The study evaluates the integration of a sexual pleasure-based approach into harm reduction services for MSM and transgender persons engaging in chemsex or substance use in Thailand, using the "Pleasuremeter" tool to improve sexual health and related outcomes.

Detailed description

This is a sequential exploratory mixed-methods implementation study conducted at IHRI clinics in Bangkok. The study includes a pre-implementation phase (qualitative interviews) and an implementation phase where the adapted "Pleasuremeter" is integrated into harm reduction services.

Approximately 300 participants will be enrolled and followed at baseline, month 3, and month 6. Outcomes include sexual pleasure, behavioral risk, substance use, HIV/STI testing, mental health, and socio-legal factors. The study also evaluates acceptability, satisfaction, and feasibility of integrating a pleasure-based approach into existing services.

Interventions

  • Behavioral Pleasuremeter-guided qualitative interview
    Semi-structured in-depth interviews guided by the Pleasuremeter framework, covering 7 domains of sexual pleasure: * Physical and psychological satisfaction * Self-determination * Consent * Safety * Privacy * Confidence * Communication/negotiation
  • Behavioral Pleasuremeter-based sexual pleasure discussion integrated with harm reduction services
    Participants will undergo: * Sexual pleasure assessment using Pleasuremeter (0-10 scale, 3-month recall) * Behavioral risk and substance use assessment * HIV/STI testing * Mental health screening using Electronic Mental Wellness Tool (e-mwTool) * Social and stigma assessment * Harm reduction services (drug literacy, counseling, referral, harm reduction kits) The intervention aims to facilitate structured discussions on sexual pleasure within harm reduction services.

Primary outcome measures

  • Willingness to engage in sexual pleasure discussions assessed using the Pleasuremeter tool [Time frame: Baseline, Month 3, and Month 6 (over 6 months follow-up)]
  • Sexual pleasure score assessed by the Pleasuremeter (0-10 scale) [Time frame: Baseline, Month 3, and Month 6]

Eligibility criteria

Inclusion criteria

  • MSM, transgender women, transgender men, or non-binary persons
  • Age ≥18 years
  • Engaged in chemsex or substance use within past 12 months
  • Able to provide informed consent

Exclusion criteria

  • Unable to communicate in Thai sufficiently to complete study procedures

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Thailand · 1 center
  • Tangerine Clinic, Institute of HIV Research and Innovation — Pathum Wan

Identifiers

NCT: NCT07509853 · IHRI040

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗